FRATTA, Mario
 Distribuzione geografica
Continente #
NA - Nord America 217
EU - Europa 210
AS - Asia 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 444
Nazione #
US - Stati Uniti d'America 217
IE - Irlanda 84
IT - Italia 31
GB - Regno Unito 26
UA - Ucraina 20
DE - Germania 14
SE - Svezia 12
BE - Belgio 6
CN - Cina 6
GR - Grecia 6
FI - Finlandia 5
FR - Francia 4
IN - India 3
PK - Pakistan 3
TR - Turchia 2
DK - Danimarca 1
EU - Europa 1
IL - Israele 1
JP - Giappone 1
RU - Federazione Russa 1
Totale 444
Città #
Dublin 84
Jacksonville 32
Ann Arbor 27
Chandler 26
New York 10
Princeton 10
Caserta 9
Roxbury 9
Woodbridge 8
Medford 7
Wilmington 6
Bremen 5
Brussels 4
Ashburn 3
Boardman 3
Cambridge 3
Kansas City 3
Karachi 3
Mountain View 3
Mumbai 3
Redwood City 3
Capua 2
Indianapolis 2
Lier 2
London 2
Nanjing 2
Auburn Hills 1
Berlin 1
Des Moines 1
Guangzhou 1
Gunzenhausen 1
Hefei 1
Helsinki 1
Lanzhou 1
Leawood 1
Milan 1
Moscow 1
Norwalk 1
Paris 1
Pullman 1
Putignano 1
Redmond 1
Sala Consilina 1
Salerno 1
San Mateo 1
Seattle 1
Taizhou 1
Ålborg 1
Totale 293
Nome #
Modifications moleculaires au cours de la regeneration et reinnervation musculaires in vitro 84
Large cardio-embolic ischemic stroke in Kearns-Sayre syndrome 64
Delayed post‐hypoxic leukoencephalopathy with a peculiar autoantibody association 61
Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis 51
Rasagiline improves sleep disorders in Parkinson's disease 49
Improvement in accuracy of diagnosis of carotid artery stenosis with duplex ultrasound scanning with combined use of linear array 7.5 MHz and convex array 3.5 MHz probes: validation versus 489 arteriographic procedures 48
ODLURO syndrome: personal experience and review of the literature 37
Expanding the spectrum of SPTLC1-related disorders beyond hereditary sensory and autonomic neuropathies: a novel case of the distinct "S331 syndrome" 30
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study 24
Paraneoplastic syndrome or immune-related adverse event? A case of rhomboencephalitis in a patient treated with Pembrolizumab 20
Totale 468
Categoria #
all - tutte 1.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.686


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 1 1
2019/202057 6 7 0 1 6 0 8 7 5 4 10 3
2020/202172 7 3 5 11 6 1 12 6 1 8 9 3
2021/202264 2 1 0 4 21 0 3 4 2 3 5 19
2022/2023162 20 2 2 4 16 12 0 9 83 5 3 6
2023/202452 7 3 4 4 20 11 0 3 0 0 0 0
Totale 468